Completed PHASE2 INTERVENTIONAL 1-arm NCT00587964

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Bladder Cancer Brain Metastasis Breast Cancer Cervical Cancer Colon Cancer HEENT Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Rectal Cancer Sarcoma Testicular Cancer

Interventions Stereotactic Radiosurgery

Updated 5 times since 2017 Last updated: Jan 22, 2016 Started: Jun 30, 2004 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Bladder Cancer and Brain Metastasis and is currently completed. Memorial Sloan Kettering Cancer Center leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Sloan Kettering Cancer Center

Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States